Extending diagnostic role of Vivosonic's Integrity 500 to include central auditory processing disorders

扩展 Vivosonic Integrity 500 的诊断作用，将中枢听觉处理障碍纳入其中

• 批准号: 495899-2016
• 负责人: Wong, Willy
• 金额: $ 1.82万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Engage Grants Program
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=604258
• 关键词: Extending; diagnostic; role; Vivosonic; Integrity

Central auditory processing disorder (CAPD) is a type of hearing disorder that affects nearly 5% of school-aged children as well as 70% of older adult population. Patients with CAPD generally have healthy peripheral hearing but deficits in the processing ability of auditory information in the central nervous system. Diagnosis is extremely important as its failure may affect children's ability to develop normally, or to communicate and have a good quality of life. This proposal seeks to extend Vivosonic's Integrity V500 auditory diagnostic system to better screen for more difficult auditory disorders like CAPD by including assessment of gap detection as well as middle latency cortical response from patients.

中枢性听觉加工障碍(CAPD)是一种听力障碍，影响近5%的学龄儿童和70%的老年人。CAPD患者的外周听力一般正常，但中枢神经系统的听觉信息处理能力存在缺陷。诊断非常重要，因为它的失败可能会影响儿童的正常发育能力，或沟通和拥有良好的生活质量。这项建议旨在扩展Vivosonic的Integrity V500听觉诊断系统，通过包括对间隙检测以及患者的中等潜伏期皮质反应的评估，更好地筛查CAPD等更难的听力障碍。